Acute Pharyngitis Market Outlook 2026–2030: Growth Trends, Market Dynamics And Emerging Opportunities
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Acute Pharyngitis Market Forecast: What Value Will The Market Reach By 2030?
The acute pharyngitis market has shown considerable expansion in recent years. Its valuation is anticipated to rise from $2.89 billion in 2025 to $3.13 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.2%. Historically, this growth can be attributed to a high prevalence of viral and bacterial pharyngitis, limited awareness concerning treatment options, enhancements in healthcare infrastructure, an increase in outpatient visits, and the expanding availability of pharmaceutical products.
The acute pharyngitis market size is set to observe significant growth in the upcoming years. It is forecast to reach $4.25 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.0%. This expansion during the projection period stems from the advancement of novel antivirals and antibiotics, heightened adoption of telemedicine, the proliferation of online pharmacy platforms, increased understanding of herbal and alternative remedies, and the expansion of homecare and specialty care offerings. Prominent trends for the forecast period include a rising application of antibiotics and antivirals for acute pharyngitis, a growing uptake of over-the-counter medications, an increasing preference for herbal and alternative remedies, the broadening of hospital and homecare treatment choices, and a focus on anti-inflammatory and corticosteroid therapies.
Get A Free Sample Report With In-Depth Market Insights:
Acute Pharyngitis Market Industry Drivers: What’s Behind The Revenue Growth?
An increase in influenza prevalence is anticipated to boost the acute pharyngitis market going forward. Influenza results from infection with influenza viruses, which are transmitted through respiratory droplets from coughing, sneezing, or contact with contaminated surfaces. The heightened prevalence of influenza is linked to factors such as seasonal variations, low vaccination rates, increased human mobility, viral mutations, and weakened immunity in certain populations. Acute pharyngitis treatment aids influenza patients by relieving throat inflammation and pain, reducing swallowing discomfort, preventing secondary bacterial infections, and supporting overall recovery. When combined with antiviral medications, adequate hydration, and rest, this treatment enhances the body’s ability to fight the influenza virus more effectively. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, by February 2025, the proportion of positive clinical lab tests for influenza reached 31.6%, having risen from 29.4% in the preceding week and 18.6% at the year’s outset. Therefore, the increasing prevalence of influenza is propelling the growth of the acute pharyngitis market.
Acute Pharyngitis Market Segments: Where Is Growth Concentrated?
The acute pharyngitis market covered in this report is segmented –
1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users
Subsegments:
1) By Antibiotics: Penicillins, Cephalosporins, Macrolides
2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs
3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups
4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
#Acute Pharyngitis Market Growth Trends: What’s Shaping The Future Outlook?
Companies prominently involved in the acute pharyngitis market are concentrating on developing advanced solutions, such as multiplex syndromic POC testing, to improve diagnostic speed, enhance accuracy, and support treatment decisions specific to pathogens. Multiplex POC testing represents a technological approach designed to detect multiple pathogens from a single sample rapidly, enabling clinicians to differentiate between viral and bacterial infections and reduce unnecessary antibiotic use. For instance, in June 2024, bioMérieux, a France-based medical equipment manufacturer, secured FDA Special 510(k) clearance and a CLIA waiver for its BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini. This panel identifies common viral causes of sore throat as well as Group A Streptococcus from a single throat or nasopharyngeal swab in approximately 15 minutes. The test operates on the BIOFIRE SPOTFIRE platform, providing clinicians the option to select a small or larger multiplex respiratory panel depending on their specific needs and setting. The Mini panel shows strong sensitivity for four respiratory viruses, including rhinovirus and influenza, and for Streptococcus A, aiding clinicians in making rapid, targeted treatment decisions.
Acute Pharyngitis Market Key Participants And Competitive Landscape
Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Lupin Limited, Alkem Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited
View The Full Acute Pharyngitis Market Report:
Acute Pharyngitis Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the acute pharyngitis market in 2025. The regions covered in the acute pharyngitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
